{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T09:19:30Z","timestamp":1760347170922,"version":"3.30.2"},"reference-count":41,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","elsevier.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Actas Urol\u00f3gicas Espa\u00f1olas (English Edition)"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.acuroe.2024.09.004","type":"journal-article","created":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T21:00:09Z","timestamp":1727125209000},"page":"732-738","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Clinical application of the UroLift\u00ae prostatic urethral lift in Spain: consensus on the treatment of lower urinary tract symptoms associated with urinary flow obstruction and secondary to benign prostatic hyperplasia (BPH)"],"prefix":"10.1016","volume":"48","author":[{"given":"M.","family":"Fern\u00e1ndez Arjona","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"L\u00f3pez Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.M.","family":"Herranz Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Sinues Ojas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.M.","family":"Camp\u00e1 Bortol\u00f3","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Extramiana Cameno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"L\u00f3pez Alcina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Povo Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Bud\u00eda Alba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Ordaz Jurado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.M.","family":"Osca Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Per\u00e1n Teruel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Gimeno Argente","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Navarro Beltr\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Benejam Gual","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.E.","family":"Hern\u00e1ndez Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Gonz\u00e1lez Enguita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.acuroe.2024.09.004_bib0005","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1097\/JU.0000000000002183","article-title":"Management of lower urinary tract symptoms attributed to benign prostatic hyperplasia: AUA GUIDELINE PART I d initial work-up and medical management","volume":"206","author":"Lerner","year":"2021","journal-title":"J Urol"},{"key":"10.1016\/j.acuroe.2024.09.004_bib0010","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.semerg.2015.07.005","article-title":"[Relationship between lower urinary tract symptoms in men and erectile dysfunction]","volume":"42","author":"Alc\u00e1ntara Montero","year":"2016","journal-title":"Semergen"},{"key":"10.1016\/j.acuroe.2024.09.004_bib0015","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S0210-4806(10)70007-3","article-title":"Criterios de derivaci\u00f3n en hiperplasia benigna de pr\u00f3stata para atenci\u00f3n primaria","volume":"34","author":"Casti\u00f1eiras Fern\u00e1ndez","year":"2010","journal-title":"Actas urol esp"},{"issue":"3","key":"10.1016\/j.acuroe.2024.09.004_bib0020","first-page":"97","article-title":"Documento de consenso sobre pautas de actuaci\u00f3n y seguimiento del var\u00f3n con s\u00edntomas del tracto urinario inferior secundarios a hiperplasia prost\u00e1tica benigna","volume":"5","author":"Brenes Berm\u00fadez","year":"2016","journal-title":"Med Gen y Fam"},{"key":"10.1016\/j.acuroe.2024.09.004_bib0025","first-page":"S122","article-title":"BPH: epidemiology and comorbidities","volume":"12","author":"McVary","year":"2006","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.acuroe.2024.09.004_bib0030","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1097\/01.ju.0000155709.37840.fe","article-title":"Urologic diseases in America project: benign prostatic hyperplasia","volume":"173","author":"Wei","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.acuroe.2024.09.004_bib0035","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1056\/NEJMoa030656","article-title":"The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia","volume":"349","author":"McConnell","year":"2003","journal-title":"N Engl J Med"},{"year":"2023","series-title":"EAU Guidelines on Non-Neurogenic Male Lower Urinary Tract Symptoms (LUTS), incl","author":"Cornu","key":"10.1016\/j.acuroe.2024.09.004_bib0040"},{"key":"10.1016\/j.acuroe.2024.09.004_bib0045","doi-asserted-by":"crossref","first-page":"E79","DOI":"10.1111\/bju.14584","article-title":"Long-term cost comparison between surgical and medical therapy for benign prostatic hyperplasia: a study using hospital billing data","volume":"123","author":"Ahn","year":"2019","journal-title":"BJU Int"},{"year":"2021","series-title":"UroLift for treating lower urinary tract symptoms of benign prostatic hyperplasia MTG 58","key":"10.1016\/j.acuroe.2024.09.004_bib0050"},{"issue":"Suppl 3","key":"10.1016\/j.acuroe.2024.09.004_bib0055","first-page":"S9","article-title":"Economic impact of surgical intervention in the treatment of benign prostatic hyperplasia","volume":"8","author":"Hollingsworth","year":"2006","journal-title":"Rev Urol"},{"key":"10.1016\/j.acuroe.2024.09.004_bib0060","article-title":"Defining minimal invasive surgical therapy for benign prostatic obstruction surgery: Perspectives from a global knowledge, attitudes, and practices survey","author":"Kwun-Chung Cheng","year":"2022","journal-title":"Asian J Urol."},{"issue":"529","key":"10.1016\/j.acuroe.2024.09.004_bib0065","article-title":"Epidemiology and treatment modalities for the management of benign prostatic hyperplasia","volume":"8","author":"Lokeshwar","year":"2019","journal-title":"Transl Androl Urol"},{"key":"10.1016\/j.acuroe.2024.09.004_bib0070","first-page":"1","article-title":"EAU: Guidelines on Male Lower Urinary Tract Symptoms (LUTS), including Benign Prostatic Obstruction (BPO)","author":"Gravas","year":"2022","journal-title":"Eur Assoc Urol"},{"key":"10.1016\/j.acuroe.2024.09.004_bib0075","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1016\/j.juro.2013.05.116","article-title":"The prostatic urethral lift for the treatment of lower urinary tract symptoms associated with prostate enlargement due to benign prostatic hyperplasia: the L.I.F.T. Study","volume":"190","author":"Roehrborn","year":"2013","journal-title":"J Urol"},{"key":"10.1016\/j.acuroe.2024.09.004_bib0080","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.euros.2020.05.001","article-title":"A systematic review and meta-analysis of prostatic urethral lift for male lower urinary tract symptoms secondary to benign prostatic hyperplasia","volume":"19","author":"Xiang","year":"2020","journal-title":"Eur Urol Open Sci"},{"key":"10.1016\/j.acuroe.2024.09.004_bib0085","first-page":"8802","article-title":"Five year results of the prospective randomized controlled prostatic urethral L.I.F.T. study","volume":"24","author":"Roehrborn","year":"2017","journal-title":"Canadian J Urol"},{"key":"10.1016\/j.acuroe.2024.09.004_bib0090","first-page":"79","article-title":"The UroLift implant: mechanism behind rapid and durable relief from prostatic obstruction","volume":"25","author":"Roehrborn","year":"2022","journal-title":"Clin Res."},{"key":"10.1016\/j.acuroe.2024.09.004_bib0095","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.eururo.2015.04.024","article-title":"Prospective, randomized, multinational study of prostatic urethral lift versus transurethral resection of the prostate: 12-month results from the BPH6 study","volume":"68","author":"S\u00f8nksen","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.acuroe.2024.09.004_bib0100","first-page":"7094","article-title":"Prospective multi-center study elucidating patient experience after prostatic urethral lift","volume":"21","author":"Shore","year":"2014","journal-title":"Canadian Journal of Urology"},{"key":"10.1016\/j.acuroe.2024.09.004_bib0105","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1089\/end.2019.0167","article-title":"Real-world evidence of prostatic urethral lift confirms pivotal clinical study results: 2-year outcomes of a retrospective multicenter study","volume":"33","author":"Eure","year":"2019","journal-title":"J Endourol"},{"key":"10.1016\/j.acuroe.2024.09.004_bib0110","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1097\/JU.0000000000001778","article-title":"Final 5-year outcomes of the multicenter randomized sham-controlled trial of a water vapor thermal therapy for treatment of moderate to severe lower urinary tract symptoms secondary to benign prostatic hyperplasia","volume":"206","author":"McVary","year":"2021","journal-title":"J Urol"},{"key":"10.1016\/j.acuroe.2024.09.004_bib0115","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/jsm.12333","article-title":"Treatment of LUTS secondary to BPH While preserving sexual function: randomized controlled study of prostatic urethral lift","volume":"11","author":"Mcvary","year":"2014","journal-title":"J Sex Med"},{"key":"10.1016\/j.acuroe.2024.09.004_bib0120","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1111\/j.1743-6109.2011.02568.x","article-title":"Preservation of sexual function with the prostatic urethral lift: a novel treatment for lower urinary tract symptoms secondary to benign prostatic hyperplasia","volume":"9","author":"Woo","year":"2012","journal-title":"J Sex Med"},{"key":"10.1016\/j.acuroe.2024.09.004_bib0125","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.eururo.2013.01.008","article-title":"Minimally invasive prostatic urethral lift: surgical technique and multinational experience","volume":"64","author":"McNicholas","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.acuroe.2024.09.004_bib0130","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/s41391-018-0118-x","article-title":"Prostatic Urethral Lift (PUL) for obstructive median lobes: 12 month results of the MedLift Study","volume":"22","author":"Rukstalis","year":"2019","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.acuroe.2024.09.004_bib0135","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1111\/bju.13714","article-title":"Prostatic urethral lift vs transurethral resection of the prostate: 2-year results of the BPH6 prospective, multicentre, randomized study","volume":"119","author":"Gratzke","year":"2017","journal-title":"BJU Int"},{"key":"10.1016\/j.acuroe.2024.09.004_bib0140","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1097\/01.ju.0000078083.38675.79","article-title":"AUA Guideline on management of benign prostatic hyperplasia (2003). Chapter 1: diagnosis and treatment recommendations","volume":"170","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.acuroe.2024.09.004_bib0145","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1038\/s41366-020-00677-2","article-title":"Obesity is a potential risk factor contributing to clinical manifestations of COVID-19","volume":"44","author":"Kang","year":"2020","journal-title":"Int J Obes"},{"issue":"683","key":"10.1016\/j.acuroe.2024.09.004_bib0150","article-title":"Association of Suicidality and Depression With 5\u03b1-Reductase Inhibitors","volume":"177","author":"Welk","year":"2017","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.acuroe.2024.09.004_bib0155","doi-asserted-by":"crossref","DOI":"10.1515\/hmbci-2017-0015","article-title":"Long-term dutasteride therapy in men with benign prostatic hyperplasia alters glucose and lipid profiles and increases severity of erectile dysfunction","author":"Traish","year":"2017","journal-title":"Horm Mol Biol Clin Investig."},{"key":"10.1016\/j.acuroe.2024.09.004_bib0160","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.l1204","article-title":"Incidence of type 2 diabetes mellitus in men receiving steroid 5\u03b1-reductase inhibitors: population based cohort study","author":"Wei","year":"2019","journal-title":"The BMJ."},{"key":"10.1016\/j.acuroe.2024.09.004_bib0165","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jns.2017.05.064","article-title":"The risk of dementia with the use of 5 alpha reductase inhibitors","volume":"379","author":"Welk","year":"2017","journal-title":"J Neurol Sci"},{"issue":"100209","key":"10.1016\/j.acuroe.2024.09.004_bib0170","article-title":"Post-finasteride syndrome: An emerging clinical problem","volume":"12","author":"Diviccaro","year":"2020","journal-title":"Neurobiol Stress"},{"key":"10.1016\/j.acuroe.2024.09.004_bib0175","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1097\/JU.0000000000001561","article-title":"Cardiac failure associated with medical therapy of benign prostatic hyperplasia: a population based study","volume":"205","author":"Lusty","year":"2021","journal-title":"J Urol"},{"key":"10.1016\/j.acuroe.2024.09.004_bib0180","article-title":"Efficacy and side effects of drugs commonly used for the treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia","author":"Yu","year":"2020","journal-title":"Front Pharmacol."},{"key":"10.1016\/j.acuroe.2024.09.004_bib0185","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.jcrs.2005.02.027","article-title":"Intraoperative floppy iris syndrome associated with tamsulosin","volume":"31","author":"Chang","year":"2005","journal-title":"J Cataract Refract Surg"},{"key":"10.1016\/j.acuroe.2024.09.004_bib0190","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1503\/cmaj.150624","article-title":"Risk of ischemic stroke during the initiation period of \u03b1-blocker therapy among older men","volume":"188","author":"Lai","year":"2016","journal-title":"CMAJ"},{"key":"10.1016\/j.acuroe.2024.09.004_bib0195","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1002\/pds.4361","article-title":"Tamsulosin and the risk of dementia in older men with benign prostatic hyperplasia","volume":"27","author":"Duan","year":"2018","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.acuroe.2024.09.004_bib0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12894-015-0090-x","article-title":"Patient\u2019s adherence on pharmacological therapy for benign prostatic hyperplasia (BPH)-associated lower urinary tract symptoms (LUTS) is different: is combination therapy better than monotherapy","volume":"15","author":"Cindolo","year":"2015","journal-title":"BMC Urol"},{"key":"10.1016\/j.acuroe.2024.09.004_bib0205","unstructured":"Asociaci\u00f3n Espa\u00f1ola de Urolog\u00eda AEU Puntuaci\u00f3n internacional de los s\u00edntomas prost\u00e1ticos-IPSS. https:\/\/www.aeu.es\/PDF\/IPSS.pdf. Accessed 3 Oct 2022."}],"container-title":["Actas Urol\u00f3gicas Espa\u00f1olas (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173578624001082?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173578624001082?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T23:39:35Z","timestamp":1734046775000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2173578624001082"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":41,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S2173578624001082"],"URL":"https:\/\/doi.org\/10.1016\/j.acuroe.2024.09.004","relation":{},"ISSN":["2173-5786"],"issn-type":[{"type":"print","value":"2173-5786"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical application of the UroLift\u00ae prostatic urethral lift in Spain: consensus on the treatment of lower urinary tract symptoms associated with urinary flow obstruction and secondary to benign prostatic hyperplasia (BPH)","name":"articletitle","label":"Article Title"},{"value":"Actas Urol\u00f3gicas Espa\u00f1olas (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.acuroe.2024.09.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.acuro.2024.06.003","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 AEU. Published by Elsevier Espa\u00f1a, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}